About Block Biosciences
Block Biosciences develops small‑molecule drugs and tools to block cancer spread to the brain and identify high‑risk patients.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Pre-Seed
Global Headquarters
Hamilton, Canada
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
blockbiosciences.com
Domain Registered Date
May 14, 2025
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Pre-Seed announced
- Milestone
Website domain registered
blockbiosciences.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Block Biosciences.
Funding History
Pre-Seed equity
· Mar 5, 2026
Undisclosed
Founders & Leadership
Agata Kieliszek
Co-Founder and CEO
Work email & phone locked
Unlock →
Amie Phinney
Co-Founder, Head of Strategy & Business
Work email & phone locked
Unlock →
Jakob Magolan
Co-Founder and Head of Chemistry
Work email & phone locked
Unlock →
Sheila Singh
Co-Founder and CSO
Work email & phone locked
Unlock →
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026